Jasper Therapeutics, Inc.

SEC 4 · Filed

0001213900-26-014244Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 6, 2026

Grant, award or other acquisition by Mahal Jeetinder Singh

Security
Stock Option (right to buy)
Code
A
Shares
500,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-06",
  "direction": "A",
  "exercise_price": "1.35",
  "expiration": "2036-02-06",
  "footnotes": {
    "F1": "1/4th of the shares subject to the option shall vest on February 6, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person\u0027s continuous service to the Issuer on and through each applicable vesting date, inclusive."
  },
  "owners": [
    {
      "cik": "0001882877",
      "name": "Mahal Jeetinder Singh",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO and President"
    }
  ],
  "ownership": "D",
  "post_shares": "500000",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "500000",
  "table": "II",
  "underlying_security": "Voting Common Stock",
  "underlying_shares": "500000"
}